T3D Therapeutics

Durham, United States

T3D Therapeutics is a company developing remedial therapeutics for Alzheimer’s disease and other CNS disorders.

$6.0M raised

Sep 2022

Venture - Series Unknown

Biotechnology Medical Therapeutics

Top Investors

National Institute on Aging

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about T3D Therapeutics

How much funding has T3D Therapeutics raised?

T3D Therapeutics has raised $6.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2022.

Who are T3D Therapeutics's investors?

T3D Therapeutics's investors include National Institute on Aging.

Where is T3D Therapeutics headquartered?

T3D Therapeutics is headquartered in Durham, United States.

What does T3D Therapeutics do?

T3D Therapeutics is a company developing remedial therapeutics for Alzheimer’s disease and other CNS disorders.

What stage is T3D Therapeutics at?

T3D Therapeutics is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 3, 2022.

MLA

"T3D Therapeutics — Funding & Investors." VCBacked, September 3, 2022, https://www.vcbacked.co/company/t3d-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2022). T3D Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/t3d-therapeutics

Wikipedia (cite web)

{{cite web |title=T3D Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/t3d-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 3, 2022.